High-sensitive cardiac troponin, NT-proBNP, hFABP and copeptin levels in relation to glomerular filtration rates and a medical record of cardiovascular disease.

作者: Christian Bjurman , Max Petzold , Per Venge , Julia Farbemo , Michael L.X. Fu

DOI: 10.1016/J.CLINBIOCHEM.2015.01.008

关键词: Troponin INatriuretic peptideCystatin CCopeptinCreatinineBiomarker (medicine)Internal medicineTroponin TRenal functionMedicineCardiology

摘要: Abstract Background Elevation of cardiac markers in patients with renal dysfunction has not been fully assessed reducing the diagnostic usefulness these biomarkers. Objective To examine effects function and a medical record cardiovascular disease on levels Methods Serum samples were collected from 489 referred for GFR measurement using Cr51-EDTA or iohexol plasma clearance (measured GFR). The biomarkers Troponin T (hs-cTnT), I (hsTnI), N-Terminal pro-Brain Natriuretic Peptide (NTproBNP), Copeptin, Human Fatty Acid-Binding Protein (hFABP), as well kidney creatinine cystatin C, measured. Regression was used to analyse relationship between biomarker glomerular filtration rate (GFR) 15 90 mL/min/1.73 m 2 . Results Compared normal function, estimated increases studied at 15 mL/min/1.73 m varied 2-fold 15-fold but very different without most prominent low molecular weight. hs-cTnT correlated more strongly measured increased compared hs-cTnI. For hFABP NTproBNP correctly predicted by local Cystatin C-based eGFR formula creatinine-based (using MDRD CKD-EPI equations). Conclusion extent elevation is highly variable. provides better predictions equations.

参考文章(42)
Saif Anwaruddin, Donald M. Lloyd-Jones, Aaron Baggish, Annabel Chen, Daniel Krauser, Roderick Tung, Claudia Chae, James L. Januzzi, Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study Journal of the American College of Cardiology. ,vol. 47, pp. 91- 97 ,(2006) , 10.1016/J.JACC.2005.08.051
Sergio Manzano-Fernández, James Louis Januzzi, Miguel Boronat-García, Patricia Pastor, María Dolores Albaladejo-Otón, Iris P. Garrido, Antoni Bayes-Genis, Mariano Valdés, Domingo A. Pascual-Figal, Impact of kidney dysfunction on plasma and urinary N-terminal pro-B-type natriuretic peptide in patients with acute heart failure. Congestive Heart Failure. ,vol. 16, pp. 214- 220 ,(2010) , 10.1111/J.1751-7133.2010.00153.X
Roland R.J. van Kimmenade, James L. Januzzi, Jaap A. Bakker, Alphonse J. Houben, Roger Rennenberg, Abraham A. Kroon, Harry J.G.M. Crijns, Marja P. van Dieijen-Visser, Peter W. de Leeuw, Yigal M. Pinto, Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects. Journal of the American College of Cardiology. ,vol. 53, pp. 884- 890 ,(2009) , 10.1016/J.JACC.2008.11.032
Kenan Yalta, Tulin Yalta, Nasir Sivri, Ertan Yetkin, Copeptin and cardiovascular disease: a review of a novel neurohormone. International Journal of Cardiology. ,vol. 167, pp. 1750- 1759 ,(2013) , 10.1016/J.IJCARD.2012.12.039
Paul Muntner, Devin Mann, Jonathan Winston, Sameer Bansilal, Michael E. Farkouh, Serum cystatin C and increased coronary heart disease prevalence in US adults without chronic kidney disease. American Journal of Cardiology. ,vol. 102, pp. 54- 57 ,(2008) , 10.1016/J.AMJCARD.2008.02.098
Helena Lappalainen, Eero Tiula, Lasse Uotila, Matti Mänttäri, Elimination kinetics of myoglobin and creatine kinase in rhabdomyolysis: Implications for follow-up Critical Care Medicine. ,vol. 30, pp. 2212- 2215 ,(2002) , 10.1097/00003246-200210000-00006
Susan Vickery, Christopher P. Price, R. Ian John, Nasir A. Abbas, Michelle C. Webb, Michelle E. Kempson, Edmund J. Lamb, B-Type Natriuretic Peptide (BNP) and Amino-Terminal proBNP in Patients With CKD: Relationship to Renal Function and Left Ventricular Hypertrophy American Journal of Kidney Diseases. ,vol. 46, pp. 610- 620 ,(2005) , 10.1053/J.AJKD.2005.06.017
Johan Lassus, Veli-Pekka Harjola, Cystatin C: a step forward in assessing kidney function and cardiovascular risk Heart Failure Reviews. ,vol. 17, pp. 251- 261 ,(2012) , 10.1007/S10741-011-9242-6
Tomas Jernberg, Bertil Lindahl, Stefan James, Anders Larsson, Lars-Olof Hansson, Lars Wallentin, Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome. Circulation. ,vol. 110, pp. 2342- 2348 ,(2004) , 10.1161/01.CIR.0000145166.44942.E0
Annette Plüddemann, Claudine Neyen, Siamon Gordon, Macrophage scavenger receptors and host-derived ligands Methods. ,vol. 43, pp. 207- 217 ,(2007) , 10.1016/J.YMETH.2007.06.004